You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
Speaker | Hannah Florance, Ph.D.
Affiliation | Agilent Technologies | Field Applications Specialist
Standardizing targeted metabolomics studies using Agilent 6495 LC/TQ in concert with biocrates
Part of the Webinar
From zero to metabolomics hero
Metabolomics and lipidomics are areas of research which have grown hugely over the last 10-15 years. The focus is often on the non-targeted approaches. As knowledge of organism metabolomes and lipidomes has grown, so has the coverage and understanding of metabolic pathways and their networks. Researchers can now focus on key metabolites as markers of well curated pathways known to be impacted by many conditions and changes. This is enabling the emphasis to shift towards targeted approaches. This in turn, provides repeatable sample preparation and analysis with out-of-the-box solutions, such as the biocrates kit. With the new Agilent LC/TQ technologies, the number of metabolites which can be analysed concurrently continues to improve with shorter dwell times, faster polarity switching and increased sensitivity with the aid of improved signal: noise ratios. We show how the Agilent 6495 LC/TQ utilizes these attributes to be a leading multi omics platform for targeted metabolomics, lipidomics and proteomics. This webinar discusses how biocrates solutions such as such as the MxP® Quant 500 XL kit fits seamlessly into this platform.
Related articles
- Population based medicine – Transform medicine with metabolomics – part 4 of 5
- Spermidine : Unlocking the secrets of cellular aging and longevity
- Precision medicine – Transform medicine with metabolomics – part 3 of 5
- Propionic acid – A short-chain fatty acid with big impact
- Predictive medicine – Transform medicine with metabolomics – part 2 of 5
